Table 4.
Deaths (%) of all SARS-Cov2 positive cases (18 + Ages) after Jan 30th.
| Vaccine type | Total rate (death) | > 50 rate (death) | < 50 rate (death) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Rate (total) | LCL UCL |
OR | Rate (total) | LCL UCL |
OR | Rate (total) | LCL UCL |
OR | |
| Unvaccinated |
1.33 (810) |
1.21 1.45 |
NA |
5.65 (593) |
5.09 6.25 |
NA |
0.43 (217) |
0.36 (0.51) |
NA |
| Sinopharm |
0.46 (112) |
0.36 0.58 |
2.9 |
1.53 (103) |
1.18 1.95 |
3.8 |
0.05 (9) |
0.02 0.11 |
8.4 |
| Sputnik V |
0.09 (3) |
0.01 0.29 |
15.4 |
0.79 (3) |
0.13 2.65 |
7.5 |
0 (0) |
0.00 0.13 |
inf |
| Pfizer-BioNtech |
0.15 (3) |
0.02 0.50 |
9.0 |
0.69 (3) |
0.11 2.32 |
8.6 |
0 (0) |
0.00 0.25 |
*inf |
| Covishield |
0.03 (1) |
0.00 0.22 |
39.7 |
0 (0) |
0.00 0.68 |
inf |
0.04 (1) |
0.00 0.27 |
**10.3 |
Death rates% as percentages of PCR positive cases in populations broken down by vaccine type, and age > 50 and < 50 over the time period of Jan 30th 2020—July 17th 2021. Tables for April 1-July 17th (when the AZ/Covishield and Sputnik V vaccines were deployed) are in Supplementary figures. Only vaccinated cases that tested positive 14 days after their final dose were included. UCL refers to Upper Confidence Limit while LCL refers to Lower Confidence Limit.
*P-value is 0.029. ** P-value is 0.0019. All other p-values are < 0.001 in pairwise comparisons to unvaccinated individuals.